Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
AudioEye, Inc. (AEYE)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
$12.06-6.44%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.14 → 1.25 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for AEYE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Grow adjusted EBITDA to at least $12 million in 2026 | Adjusted EBITDA is targeted at $12 million, showing improving profitability. | Improving | Adjusted EBITDA remains below $10 million in 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a small-cap technology growth business, not yet a durable compounder, because its earnings record remains uneven and the evidence is limited. The long-term thesis is in a watch state: recent momentum improved, but performance remains below its industry cohort.
The valuation is expensive versus peers, while the expectations gap is moderate. The priced-in signal is marked unjustified, but its fragility tier is low, so the evidence does not show a full stack of expensive valuation, weak fundamentals, and turbulence.
Near-term results show progress: Q3 revenue rose 7%, ARR grew 12% year over year, and Adjusted EBITDA and GAAP net income improved. Management also launched two AI accessibility products, while gross profit and adjusted gross margin increased; however, earnings remain erratic and the small-cap risk is elevated.
Over the next few quarters, the thesis depends on continued recurring-revenue growth, operating leverage, and evidence that the new products contribute to the business. A reversal of recently raised guidance would damage management credibility, while lower interest rates or steadier results from major technology companies could support the sector backdrop.
The 1-to-3-year view is improving but still uncertain: recent execution is encouraging, yet elevated risk and below-cohort performance call for continued evidence of durable progress. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| EPS is expected to rise to at least $0.96 per share, reflecting better earnings. |
| Under Pressure |
| EPS falls below $0.72 per share in 2026 |
Diluted EPS: $0.08 per share FY2026-Q3; GAAP. Published target: >= $0.96. Annual target cannot be compared with a quarterly or TTM observation. Oct 26, 20260.08 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain positive cash flow from operations | The company maintains positive cash flow to support growth. | Improving | Operating cash flow turns negative for two consecutive quarters | Cash from operations: $1.758M FY2026-Q3; GAAP. Published target: Positive cash flow quarterly. Target period is not explicitly aligned with this observation. Oct 26, 20261,758,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve full-year 2026 revenue near $43.75 million | A primary condition in AudioEye, Inc.'s published investment case. The stated target is ~$43.75M. | Intact | Full-year 2026 revenue falls below $40 million | Revenue: $10.963M FY2026-Q3; GAAP. Published target: ~$43.75M. Annual target cannot be compared with a quarterly or TTM observation. Oct 26, 202610,963,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.13 → $1.25 · observed estimates
$0.05B → $0.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-07-25 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-07-26 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-07-27 | $1.13 | $48,445,500 | 3 / 3 |
| 2026-07-28 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-07-29 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-07-30 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-07-31 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-01 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-02 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-03 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-04 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-05 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-06 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-07 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-08 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-09 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-10 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-11 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-12 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-13 | $1.13 | $48,445,500 | 4 / 4 |
| 2026-08-14 | $1.13 | $48,456,250 | 3 / 3 |
| 2026-08-15 | $1.13 | $48,456,250 | 3 / 3 |
| 2026-08-16 | $1.13 | $48,456,250 | 3 / 3 |
| 2026-08-17 | $1.13 | $48,456,250 | 3 / 3 |
| 2026-08-18 | $1.13 | $48,456,250 | 3 / 3 |
| 2026-08-19 | $1.13 | $48,456,250 | 3 / 3 |
| 2026-08-20 | $1.13 | $48,456,250 | 3 / 3 |
| 2026-08-21 | $1.15 | $48,175,250 | 3 / 3 |
| 2026-08-22 | $1.15 | $48,175,250 | 3 / 3 |
| 2026-08-23 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-08-24 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-08-25 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-08-26 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-08-27 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-08-28 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-08-29 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-08-30 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-08-31 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-01 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-02 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-03 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-04 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-05 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-06 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-07 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-08 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-09 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-10 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-11 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-12 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-13 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-14 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-15 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-16 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-17 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-18 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-19 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-20 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-21 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-22 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-23 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-24 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-25 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-26 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-27 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-28 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-29 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-09-30 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-01 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-02 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-03 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-04 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-05 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-06 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-07 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-08 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-09 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-10 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-11 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-12 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-13 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-14 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-15 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-16 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-17 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-18 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-19 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-20 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-21 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-22 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-23 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-24 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-25 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-26 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-27 | $1.14 | $48,095,667 | 2 / 2 |
| 2026-10-28 | $1.25 | $48,161,000 | 2 / 2 |
| 2026-10-29 | $1.25 | $48,161,000 | 2 / 2 |
| 2026-10-30 | $1.25 | $48,161,000 | 2 / 2 |
| 2026-10-31 | $1.25 | $48,161,000 | 2 / 2 |
| 2026-11-01 | $1.25 | $48,161,000 | 2 / 2 |
| 2026-11-02 | $1.25 | $48,161,000 | 2 / 2 |
| 2026-11-03 | $1.25 | $48,161,000 | 2 / 2 |
| 2026-11-04 | $1.25 | $48,161,000 | 2 / 2 |
| 2026-11-05 | $1.25 | $48,161,000 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.